Limited utility of plasma elafin as a biomarker for skin graft‐versus‐host disease following allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

Limited utility of plasma elafin as a biomarker for skin graft‐versus‐host disease following allogeneic stem cell transplantation

Published:2021-07-16 Issue:8 Volume:46 Page:1482-1487
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:Clin Exp Dermatol

Author:

George L.¹^ORCID,Mahabal G.¹^ORCID,Mohanan E.²,Balasubramanian P.²,Peter D.¹^ORCID,Pulimood S.¹^ORCID,Lakshmi K.²,Jeyaseelan L.³,Abraham A.²,Srivastava A.²,Mathews V.²,George B.²

Affiliation:

1. Department of Dermatology, Venereology and Leprosy Christian Medical College Vellore Tamil Nadu India

2. Department of Haematology Christian Medical College Vellore Tamil Nadu India

3. Department of Biostatistics Christian Medical College Vellore Tamil Nadu India

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ced.14785

Reference17 articles.

1. Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity

2. A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment

3. Many faces of graft-versus-host disease

4. Acute graft-versus-host disease following hematopoietic stem-cell transplantation

5. Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactions

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants;Frontiers in Immunology;2024-02-16

2. Evaluation of elafin as a marker of skin fibrosis – a preliminary study.;2023-12-21

3. Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review;Hematology;2023-12-19

4. Biomarkers for early complications post hematopoietic cell transplantation: Insights and challenges;Frontiers in Immunology;2023-02-02

5. Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease;Transplantation and Cellular Therapy;2022-10